[New post] Apellis (APLS) Gets CHMP Nod for Rare Blood Disorder Drug (Revised)

Editorial Team posted: "The CHMP gives a positive opinion on and recommends granting marketing authorization to Apellis' (APLS) Aspaveli for the treatment of adults with paroxysmal nocturnal hemoglobinuria. Find out more at https://ift.tt/3vwPjJw via Entrepreneur.com" New post on Technology & Business News Apellis (APLS) Gets CHMP Nod for Rare Blood Disorder Drug (Revised) by Editorial Team The CHMP gives a positive opinion on and recommends granting marketing authorization to Apellis' (APLS) Aspaveli for the treatment of adults with paroxysmal nocturnal hemoglobinuria. Find out more at https://ift.tt/3vwPjJw via Entrepreneur.com Read more of this post This free site is ad-supported. Learn more ​ Editorial Team | October 21, 2021 at 4:10 am | Tags: Entrepreneur | Categories: Business | URL: https://wp.me/pcbvJV-aQQ Like Unsubscribe to no longer receive posts from Technology & Business News. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://technologyandbusinessnews.wordpress.com/2021/10/21/apellis-apls-gets-chmp-nod-for-rare-blood-disorder-drug-revised/ Thanks for flying with WordPress.com